Delisting of Securities from The Nasdaq Stock Market
Nasdaq (NDAQ) announced on November 7, 2025 that it will delist multiple issuers whose securities have been suspended and not traded on Nasdaq for extended periods. Affected issuers include Phoenix Motor, Petros Pharmaceuticals, Femto Technologies, Vaxart, Wang & Lee Group, Longevity Health Holdings (common stock and warrants), LakeShore Biopharma (ordinary shares and warrants), Shineco, Office Properties Income Trust (common shares of beneficial interest and 6.375% senior notes due 2050), Bollinger Innovations, Spring Valley Acquisition Corp II (Class A shares, warrants, units, and rights), and FlexShopper.
The notice cites the prior suspension dates for each issuer, ranging from April 15, 2025 through October 23, 2025, and references Nasdaq Rule 5800 Series governing delisting.
Nasdaq (NDAQ) ha annunciato il 7 novembre 2025 che rimuoverà dalla quotazione diversi emittenti le cui securities sono state sospese e non negoziate su Nasdaq per periodi prolungati. Tra gli emittenti interessati figurano Phoenix Motor, Petros Pharmaceuticals, Femto Technologies, Vaxart, Wang & Lee Group, Longevity Health Holdings (azioni ordinarie e warrant), LakeShore Biopharma (azioni ordinarie e warrant), Shineco, Office Properties Income Trust (azioni comuni di interesse benefico e obbligazioni senior del 6,375% in scadenza 2050), Bollinger Innovations, Spring Valley Acquisition Corp II ( azioni di Classe A, warrant, unit e diritti) e FlexShopper.
Il comunicato cita le date di sospensione precedenti per ciascun emittente, che vanno dal 15 aprile 2025 al 23 ottobre 2025, e fa riferimento alla Nasdaq Rule 5800 Series che regola la delisting.
Nasdaq (NDAQ) anunció el 7 de noviembre de 2025 que realizará la exclusión de cotización de múltiples emisores cuyas values han sido suspendidas y no negociadas en Nasdaq durante periodos prolongados. Entre los emisores afectados se encuentran Phoenix Motor, Petros Pharmaceuticals, Femto Technologies, Vaxart, Wang & Lee Group, Longevity Health Holdings (acciones ordinarias y warrants), LakeShore Biopharma (acciones ordinarias y warrants), Shineco, Office Properties Income Trust (acciones comunes de interés en beneficio y bonos senior del 6,375% con vencimiento en 2050), Bollinger Innovations, Spring Valley Acquisition Corp II (acciones Clase A, warrants, units y rights) y FlexShopper.
El aviso cita las fechas de suspensión anteriores para cada emisor, que van desde el 15 de abril de 2025 hasta el 23 de octubre de 2025, y hace referencia a la Nasdaq Rule 5800 Series que regula la retirada de cotización.
나스닥(NDAQ)은 2025년 11월 7일에 나스닥에서 장기간 매매 중단된 여러 발행회사의 상장폐지가 진행될 것이라고 발표했습니다. 영향을 받는 발행회사로는 Phoenix Motor, Petros Pharmaceuticals, Femto Technologies, Vaxart, Wang & Lee Group, Longevity Health Holdings(보통주 및 워런트), LakeShore Biopharma(보통주 및 워런트), Shineco, Office Properties Income Trust(유가증권의 보통주 및 6.375%의 2050년 만기 선순위채), Bollinger Innovations, Spring Valley Acquisition Corp II(클래스 A 주식, 워런트, 유닛 및 권리), 그리고 FlexShopper가 포함됩니다.
공지는 각 발행회사의 이전 매매정지 날짜를 2025년 4월 15일부터 2025년 10월 23일까지 제시하고, 상장폐지를 규정하는 Nasdaq Rule 5800 시리즈를 참조합니다.
Nasdaq (NDAQ) a annoncé le 7 novembre 2025 qu’il procédera à la radiation de plusieurs émetteurs dont les valeurs mobilières ont été suspendues et n’ont pas été négociées sur Nasdaq pendant de longues périodes. Les émetteurs concernés incluent Phoenix Motor, Petros Pharmaceuticals, Femto Technologies, Vaxart, Wang & Lee Group, Longevity Health Holdings (actions ordinaires et warrants), LakeShore Biopharma (actions ordinaires et warrants), Shineco, Office Properties Income Trust (actions ordinaires d’intérêt bénéficiaire et obligations senior à 6,375% maturing en 2050), Bollinger Innovations, Spring Valley Acquisition Corp II (actions de Classe A, warrants, units et droits) et FlexShopper.
L’avis indique les dates de suspension antérieures pour chaque émetteur, allant du 15 avril 2025 au 23 octobre 2025, et fait référence à la Nasdaq Rule 5800 Series régissant le delisting.
Nasdaq (NDAQ) kündigte am 7. November 2025 an, dass mehrere Emittenten, deren Wertpapiere suspendiert und über längere Zeiträume nicht an der Nasdaq gehandelt wurden, delistet werden. Zu den betroffenen Emittenten gehören Phoenix Motor, Petros Pharmaceuticals, Femto Technologies, Vaxart, Wang & Lee Group, Longevity Health Holdings (Stammaktien und Warrants), LakeShore Biopharma (Stammaktien und Warrants), Shineco, Office Properties Income Trust (Stammaktien betrieblicher Anteil am Nutzen und 6,375% Senior Notes fällig 2050), Bollinger Innovations, Spring Valley Acquisition Corp II (Class-A-Aktien, Warrants, Units und Rights) und FlexShopper.
Die Mitteilung nennt die früheren Suspendierungsdaten für jeden Emittenten, die vom 15. April 2025 bis zum 23. Oktober 2025 reichen, und verweist auf die Nasdaq Rule 5800 Series, die das Delisting regelt.
ناسداك (NDAQ) أعلن في 7 نوفمبر 2025 عن قيامه بسحب إدراج عدة مُصدِرين تم تعليق أدواتهم المالية وعدم تداولها في ناسداك لفترات طويلة. من بين المُصدِرين المتأثرين: Phoenix Motor، Petros Pharmaceuticals، Femto Technologies، Vaxart، Wang & Lee Group، Longevity Health Holdings (الأسهم العادية والمرافقات)، LakeShore Biopharma (الأسهم العادية والمرافقات)، Shineco، Office Properties Income Trust (الأسهم العادية ذات فائدة مع حوالة 6.375% مستحقة عام 2050)، Bollinger Innovations، Spring Valley Acquisition Corp II (أسهم من الفئة أ، مرافقات، وحدات، وحقوق)، وFlexShopper.
تشير الإخطار إلى تواريخ التعليق السابقة لكل مُصدِر، والتي تتراوح من 15 أبريل 2025 حتى 23 أكتوبر 2025، وتشير إلى قاعدة ناسداك 5800 التي تحكم سحب الإدراج.
- Nasdaq provides clear timeline for delisting actions dated Nov 7, 2025
- Investors receive definitive status on suspended securities and trading halts
- Phoenix Motor common stock suspended on Apr 15, 2025
- Petros Pharmaceuticals common stock suspended on May 22, 2025
- Longevity Health Holdings common stock and warrants suspended on Sep 12, 2025
- LakeShore Biopharma ordinary shares and warrants suspended on Sep 22, 2025
- Office Properties Income Trust common shares and 6.375% senior notes suspended on Oct 7, 2025
- Spring Valley Acquisition Corp II Class A shares, warrants, units, rights suspended on Oct 21, 2025
Insights
Nasdaq announced delisting of multiple suspended issuers; this removes these securities from the exchange effective Nov 07, 2025.
The announcement lists final delisting actions for multiple issuers whose trading had been suspended on prior dates, including Phoenix Motor Inc. (suspended
Key dependencies and risks include the prior suspension dates and the exchange’s rule framework (Nasdaq Rule 5800 Series) that govern delisting; those facts indicate formal non‑compliance or inability to maintain listing standards that triggered removal. The announcement is procedural and factual; it does not state remedies, reinstatement plans, or final outcomes for creditors or shareholders.
Watch for near‑term procedural follow‑ups: notices to shareholders about transfer options, any filings by the affected companies to appeal or seek relisting, and OTC market quotes after delisting. The relevant horizon is immediate to within the next few weeks following the
NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Phoenix Motor Inc. Phoenix Motor Inc.’s common stock was suspended on April 15, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.’s common stock was suspended on May 22, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Femto Technologies Inc. Femto Technologies Inc.’s common stock was suspended on June 23, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Vaxart, Inc. Vaxart, Inc.’s common stock was suspended on July 8, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the ordinary shares of Wang & Lee Group, Inc. Wang & Lee Group, Inc.’s ordinary shares were suspended on August 26, 2025 and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock and warrants of Longevity Health Holdings, Inc. Longevity Health Holdings, Inc.’s securities were suspended on September 12, 2025 and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the ordinary shares and warrants of LakeShore Biopharma Co, Ltd. LakeShore Biopharma Co., Ltd’s securities were suspended on September 22, 2025 and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Shineco, Inc. Shineco, Inc.’s common stock was suspended on October 7, 2025 and has not traded on Nasdaq since that time
Nasdaq also announced today that it will delist the Common Shares of Beneficial Interest and
Nasdaq also announced today that it will delist the common stock of Bollinger Innovations, Inc. Bollinger Innovations, Inc.’s stock was suspended on October 13, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the Class A Ordinary Shares, warrants, units, and rights of Spring Valley Acquisition Corp II. Spring Valley Acquisition Corp. II’s stock was suspended on October 21, 2025 and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of FlexShopper, Inc. FlexShopper, Inc.’s common stock was suspended on October 23, 2025 and has not traded on Nasdaq since that time.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.
FAQ
What did Nasdaq announce about delistings on November 7, 2025 (NDAQ)?
Which issuers will Nasdaq delist as of November 7, 2025?
When were Phoenix Motor and Petros Pharmaceuticals suspended from Nasdaq?
What Nasdaq rule governs the delisting process mentioned in the November 7, 2025 notice?
Are Nasdaq senior notes affected in the November 7, 2025 delisting notice?
What suspension date range is cited for the delisted securities in the November 7, 2025 notice?
